What's new

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 34, Status: Authorised

Apr 24, 2025 - 15:48
 0
Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 34, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Prestigious journal gets U.S. attorney letter, Trump’s HIV cuts slammed

Next Article

Lightshift to build 11-MW storage project for Virginia municipal utility

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),Mometasone (furoate) (QVM149),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0493/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 14, 2025  0

Heading and text to be inserted in Section 5.1 of the SmPC

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 10, 2025  0